[Sympathomimetics in the treatment of bronchospastic conditions].
D001281:Atrial Fibrillation / Q000139:chemically induced; D001980:Bronchi / Q000187:drug effects; D001986:Bronchial Spasm / Q000188:drug therapy*; D003327:Coronary Disease / Q000139:chemically induced; D006801:Humans; D007545:Isoproterenol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D009921:Metaproterenol / Q000627:therapeutic use; D010101:Oxygen Consumption / Q000187:drug effects; D012138:Respiratory Therapy; D013566:Sympathomimetics / Q000494:pharmacology / Q000627:therapeutic use*; D014693:Ventricular Fibrillation / Q000139:chemically induced
D013566:Sympathomimetics; D009921:Metaproterenol; D007545:Isoproterenol
Leki sympatykominetyczne w leczeniu stanów bronchospastycznych